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Psychotic-like experiences (PLEs) are part of a continuum of psychosis. Previous 
longitudinal studies highlighted a relationship between peripheral inflammation during 
childhood and onset of PLEs in adulthood. In this study, we tested if this association is 
mediated by internalising and externalising symptoms experienced during childhood and 
adolescence. To test this hypothesis, we used data from the Avon Longitudinal Study of 
Parents and Children (ALSPAC). We investigated a subsample of 4,525 individuals from this 
cohort with data on interleukin 6 (IL-6) and C-reactive protein (CRP) in childhood (age 9 
years). We measured PLEs at age 18 years, and we used latent growth curve modelling to 
estimate longitudinal trajectories of internalising and externalising symptoms from ages 9 to 
16 years. The individual predicted values of the intercept (set at baseline, 9 years) and the 
slope (rate of annual change) were then used in the mediation analysis. There was evidence 
for full mediation by the intercept of internalising symptoms. Our findings suggest that 
inflammation during childhood may be relevant for the future onset of PLEs via its 
association with a high level of internalising symptoms. These findings, although obtained 
from a non-clinical population, provide an additional step in advancing knowledge on the 
relationship between inflammation and symptoms of the psychosis continuum.  








1. Introduction  
Psychotic-like experiences (PLEs) are subclinical, attenuated, psychotic symptoms 
considered to represent the healthier end of the psychosis continuum (Unterrassner et al., 
2017, Nelson et al., 2012), but still associated with  a range of common psychiatric disorders, 
such as major depressive disorder or anxiety disorders (van Os and Reininghaus 2016). PLEs 
are typically considered benign, given their transitory nature and their relatively high 
prevalence in the general population (~7%) (Linscott and Van Os 2013). However, a non-
negligible proportion (~20%) become persistent and in some cases (~7%) predate the onset of 
a full-blown psychotic disorder (Linscott and Van Os 2013). Their often-benign nature 
notwithstanding, PLEs and psychotic disorders share etiological risk factors, demographic 
characteristics and cognitive correlates (Ermel et al., 2018, Orr et al., 2014). Thus, PLEs 
measured in the general population represent a unique opportunity to gain insight on the 
psychosis continuum.   
 
Psychotic disorders are highly debilitating and impose a severe burden on sufferers, their 
families and the wider society (Millan et al., 2016). This burden is greatly increased by the 
frequent co-occurrence of chronic physical health conditions, such as obesity, diabetes and 
cardiovascular disease (Cadenhead et al., 2018, Correll et al., 2014), which underlie the 10 to 
20 years’ drop in life-expectancy observed in sufferers (Lawrence et al., 2013).  In line with 
the hypothesis of a psychosis continuum, an increased risk of physical comorbidities has also 
been shown in individuals with PLEs (Moreno et al., 2013). The high comorbid rates of 
physical conditions and psychotic disorders/PLEs have led to the hypothesis of a shared 
pathophysiological background (Minichino et al., 2017), which, in turn, has attracted interest 




The hypothesized role of the immune system as the connecting dot between physical and 
mental health is, after the last two decades of research, receiving increasing levels of support. 
With respect to psychotic disorders, several immune loci achieved genome wide significance 
in their association with psychotic disorders (Ripke et al., 2014) and meta-analytic evidence 
showed increased levels of pro-inflammatory cytokines, such as interleukin 6 (IL-6), in 
sufferers compared to healthy controls (Pillinger et al., 2018, Miller et al., 2011, Upthegrove 
et al., 2014). Taken together, these findings led some to hypothesize a causal role for 
inflammation in psychosis (Al‐Diwani et al., 2017).  
 
A test of this hypothesis has been provided by longitudinal general-population studies that 
have established long-term links between inflammation in childhood and PLEs in young 
adulthood (Downs et al., 2013, Khandaker et al., 2014). A previous Mendelian randomization 
study from the ALSPAC cohort has also reported association between genetic variants 
regulating activity of IL-6 and risk of psychosis, suggesting reverse causality or residual 
confounding are unlikely explanations for previously reported associations between IL-6 and 
psychosis (Khandaker et al., 2018). Longitudinal general-population studies have also 
established links between a pro-inflammatory status in otherwise healthy children and 
increased levels of psychopathology in the form of internalising (i.e., anxiety, depression, or 
social withdrawal) (Ridout et al., 2014, da Silva et al., 2017, Slopen et al., 2013) and 
externalising symptoms (i.e., hyperactive, aggressive, antisocial, or oppositional behaviors) 
(Slopen et al., 2013). Inflammation during childhood has been suggested to result from a 
number of different sources (Slopen et al., 2015), including a history of psychosocial 
adversity, early-life infections and autoimmune diseases (Baumeister et al., 2016). In turn, the 
pro-inflammatory physiologic response to early adversities has recently been suggested to 




Based on these observations, and the now established link between PLEs and both 
internalizing and externalizing symptoms (Downs et al., 2013, Khandaker et al., 2014), we 
carried out this study to investigate if internalising and externalising symptoms mediate the 
association between a pro-inflammatory status in childhood and the onset of PLEs in 
adulthood. Shedding light on the association between inflammation and PLEs will improve 
understanding of the pathophysiology of the psychosis continuum. Further, it will provide a 
background for future studies investigating tailored therapeutic approaches, which are greatly 
needed especially in the prodromal phase of psychotic spectrum disorders where no effective 
interventions are currently available (Davies et al., 2018). 
 
2. Materials and methods 
2.1 Study design and participants 
We used data from the Avon Longitudinal Study of Parents and Children (ALSPAC), a 
general population birth cohort. ALSPAC is a birth cohort study designed to assess 
environmental factors during and after pregnancy that might affect the development, health, 
or wellbeing of the child (Boyd et al., 2013). 14,541 pregnant women living in Bristol, UK, 
and surrounding areas, were enrolled for the study.  (Please note that the study website 
contains details of all the data that is available through a fully searchable data dictionary and 
variable search tool: http://www.bristol.ac.uk/alspac/researchers/our-data/.) From the first 
trimester of pregnancy parents completed postal questionnaires about themselves and the 
study child’s health and development. Children were invited to attend annual assessment 





Additional children were recruited using the original enrolment definition from the 
participating children’s age 7 years onwards, increasing the number to 15,445 pregnancies to 
date (Fraser et al., 2013). Ethics approval was received from the ALSPAC Law and Ethics 
Committee and local research ethics committees. All participants provided written informed 
consent and there was no financial compensation (more details at www.alspac.bris.ac.uk).  
Our study’s analytic sample included 4,525 childrenss (singletons and first-born multiples) 
who had data on inflammation at age 9 years [measured in ALSPAC with C-reactive protein 
(CRP) and IL-6] and who did not report an infection at the time of blood collection or during 
the preceding week. 
 
2.2 Measures 
Inflammation, age 9 years 
In ALSPAC blood samples were collected from participants during the clinic visit at 9 years.  
Blood samples were collected from nonfasting participants and were immediately spun and 
frozen at −80°C. IL-6 (pg/mL) was measured by enzyme-linked immunosorbent assay (R&D 
Systems) and high-sensitivity CRP (mg/L) was measured by automated particle-enhanced 
immunoturbidimetric assay (Roche). All inter-assay coefficients of variation were less than 
5%.  In ALSPAC total sample IL-6 (IL-6 n=5,072) values ranged from 0.007 to 20.051 
pg/mL while CRP (CRP n=5,082) values ranged from 0.01 to 67.44 mg/L (60 children had 
values over 10 mg/L). Both CRP and IL-6 were log-transformed for the analyses presented 
here. 
 
Internalising and externalising symptoms, ages 9, 11, 13 and 16 years 
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Internalising and externalising symptoms, following the measurement of inflammation and 
preceding the measurement of PLEs, were assessed using the mother-rated Strengths and 
Difficulties Questionnaire (SDQ) at ages 9, 11, 13 and 16 years. The SDQ is a valid and 
reliable tool for measuring emotional and behavioural difficulties in children (Goodman 
2001). It includes 20 items related to children’s difficulties (in the past 6 months) scored on a 
3-point scale with 0 = ‘not true’, 1 = ‘somewhat true’ and 2 = ‘certainly true’. Items can be 
summed to form four scales (emotional symptoms, conduct problems, hyperactivity, and peer 
problems), or two (internalising problems, the sum of the scores on the emotional and peer 
problems items, and externalising problems, the sum of the scores on the conduct problems 
and hyperactivity items) (Goodman et al., 2010). Given their clinical relevance, internalising 
and externalising symptoms were the focus in our analysis (Fergusson et al., 2005, Reef et al., 
2011).   
 
Psychotic-like experiences, age 18 years 
Psychotic experiences were assessed through the face-to-face, semi-structured Psychosis-
Like Symptom Interview (PLIKSi) (Zammit et al., 2013). The PLIKSi has been used in 
psychiatric and epidemiological research since 2008 and consists of 12 core questions, 7 
derived from the Diagnostic Interview Schedule for Children, Version IV (DISC‐IV) (Shaffer 
et al., 2000) and 5 from the Schedules for Clinical Assessment in Neuropsychiatry (SCAN) 
(WHO 1994), version 2, and it assesses the presence of delusions (spied on, persecution, 
thoughts read, reference, control, grandiosity and other unspecified delusions), thought 
interference (broadcasting, insertion and withdrawal) and hallucinations (visual and 
auditory). The ALSPAC interviewers were trained psychology graduates and coded 
according to the definitions and rating rules for the SCAN. After cross-questioning, 
interviewers rated psychotic experiences as not present, suspected, or definitely psychotic. 
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For suspected or definite psychotic experiences, interviewers also reported the frequency; 
impact on affect, impact on social function, impact on educational/occupational function; 
help seeking from professionals; and attributions, such as fever, hypnopompic/hypnogogic 
state, or substance use. In our analysis, we defined individuals with psychosis-like symptoms 
as those with definite psychotic experiences. 
 
Covariates 
We adjusted for a number of covariates known to be associated with children’s inflammation 
and internalising and externalising symptoms but also with psychotic-like experiences. These 
included gender, ethnicity (white, non-white), maternal depression, which in ALSPAC was 
assessed with the Edinburgh Postnatal Depression Scale (EDPS) (Cox et al., 1987) at 32 
weeks of pregnancy, parental socioeconomic status at the same time-point, which we 
approximated by maternal education (below O-level, O-level only, A-level only, university 
degree or more) and paternal social class (I, II, III (non-manual), III (manual), IV, V), and 
obesity status (body mass index (BMI) above the 95th percentile for children of the same 
age) (Lobstein et al., 2004). BMI (weight (kg)/height (m)2) was measured during the clinic 
visit at age 9 years. Consistent with previous literature, we decided to use an antenatal 
maternal depression measurement as it has been found to be strongly associated with 
subsequent development of mental health problems during childhood and adulthood (Pearson 
et al., 2013).  
 
2.3 Statistical analysis 
All analyses were performed in STATA 15.0 (StataCorp 2017).  
We used latent growth curve modelling (LGM) to estimate longitudinal trajectories of 
internalising and externalising symptoms from ages 9 to 16 years. Internalising and 
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externalising symptoms were assessed at two-year intervals from 9 to 13 years and three-year 
intervals from 13 to 16 years. The individual predicted values of the intercept (set at baseline, 
9 years) and the slope (rate of annual change) were then used as mediators in the mediation 
analysis. Using the predict command in STATA we generated predictions for the out-of-
sample cases, i.e., the cases that were not used in the original estimation. In this way we were 
able to estimate the intercept and the slope for internalising and externalising symptoms in 
our whole analytic sample (n=4,525). Two mediation models (details below) were then fitted 
using seemingly unrelated regression analysis. In our mediation models, both mediators 
(internalising and externalising symptoms) and exposures (CRP or IL-6) had complete data.  
Missingness among the confounders and PLIKSi ranged from 0.08% (gender) to 44.7% 
(PLIKSi). Missing data were then imputed (20 imputed datasets) using multiple imputation 
by chained equations. We used internalising symptoms, externalising symptoms, 
inflammation and covariate data to predict missingness on PLIKSi. 
 
3. Results  
3.1 Descriptive analyses 
Table 1 shows the descriptive characteristics of our sample, including means and proportions 
for the exposures, outcome, and covariates. The distribution of males and females was similar 
in our sample, whereas, as expected given the design of ALSPAC, the majority was white 
(96%). A high proportion of mothers reported an educational level equal to or above O-level 
and the majority of our sample was in non-manual social classes (I to III). A 4% of our 
sample experienced psychosis-like symptoms at 18 years and almost 5% was obese at age 9 
years. Correlations between the study variables were low to moderate, as expected 
(Supplementary Table S1).  




In our first model, we tested the direct association between inflammatory markers (IL-6 and 
CRP) measured at 9 years and the presence of psychosis-like symptoms at age 18 years. As 
shown in Figure 1, IL-6 was associated with psychotic experiences (β=0.037; p<0.05; 
CI=0.00-0.07), but CRP was not. We therefore decided to drop CRP from all further analyses 
and focus on IL-6.  
 
Model 2a 
In this model, we tested whether the intercept or the slope of internalising symptoms 
mediated the effect of IL-6 on psychosis-like symptoms. We found that only the intercept of 
internalising symptoms mediated the association between inflammation and psychotic 
experiences (Figure 1). The indirect effect was significant (β=0.007; p<0.01; CI=0.00-0.01) 
as was the total effect (β=0.037; p<0.05; CI=0.00-0.07), whereas the direct effect of IL-6 on 
psychotic experiences was attenuated fully. These results suggest complete mediation.  
 
Model 2b 
We also explored if the intercept or the slope of externalising symptoms mediated the 
association between IL-6 and psychosis-like symptoms. We found that neither the intercept 
nor the slope of externalising symptoms mediated this association.  
 
Model 3 
In our final model, we tested if the mediator effect found was robust to adjustment for 
confounders. Table 2 shows the unstandardised coefficients in imputed and complete cases of 
model 2a after adjustment (standardised coefficients and R2 are reported in Table S2). The 
path from IL-6 at age 9 to psychosis-like symptoms at age 18 via internalising symptoms at 
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age 9 was significant even after adjustment (indirect effect: β=0.005; p<0.01; CI=0.00-0.00).  
 
4. Discussion 
To the best of our knowledge this is the first study showing a mediator effect of internalising, 
but not externalising, symptoms on the positive association between levels of IL-6 at age 9 
and PLEs at age 18. The mediator effect persisted after adjusting for several potential 
confounders, including gender, ethnicity, BMI, social class, and maternal education and 
depression.  
 
The finding of an association between inflammation and PLEs is not new and is in line with 
existing evidence (Khandaker et al., 2014, Khandaker et al., 2015, Al‐Diwani et al., 2017). 
More recently, a meta-analysis also suggested that elevated IL-6 might represent a core 
component of the pathophysiology of psychosis (Pillinger et al., 2018). This cytokine can 
cross the blood-brain barrier (Wang and Miller 2017), induce microglial activation (Streit et 
al., 2000) and influence secondary brain changes in areas of relevance for the psychosis 
continuum, in line with evidence showing that inflammation has a key role in the modulation 
of neurodevelopment (Jiang et al., 2018).  
 
The association between inflammation and internalising symptoms also confirms previous 
findings implicating inflammatory proteins in the neurobiology of internalising disorders in 
children (Slopen et al., 2013). However, most of the findings are from cross-sectional studies. 
Our study, using longitudinal data, shows an association of IL-6 in childhood (age 9 years) 
with the intercept, but not the slope, of the internalising symptoms trajectory from childhood 
to adolescence (ages 9-16 years). This suggests that inflammation and internalising symptoms 
in late childhood are concurrently associated but inflammation in late childhood is not related 
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to how internalising symptoms change from late childhood to late adolescence, a period 
characterized by hormonal changes known to influence brain development and inflammation 
(da Silva et al., 2017). Fluctuations in sex hormones could thus be considered as a possible 
explanation for this null finding. 
Our main contribution to the literature is, as discussed, that the longitudinal association 
between inflammation in childhood and the onset of psychotic like experiences in adulthood 
is mediated by childhood internalising (but not externalising) psychopathology. Internalising 
symptoms are more tightly linked to the pathophysiology of the psychosis continuum than 
externalising symptoms are and high rates of internalising symptoms have been described in 
the prodromal phase of psychotic disorders (Fusar-Poli et al., 2012). Further, internalising 
symptoms, similar to inflammation, but unlike externalising symptoms, are associated with 
an increased risk of developing chronic physical comorbidities (van de Pavert et al., 2017), 
highly prevalent in psychosis sufferers (Hert et al., 2011). This suggests a shared 
pathophysiological background between inflammation, internalising symptoms and PLEs, 
which could explain our findings. 
  
Our study has some important limitations that we must acknowledge. First, inflammation was 
only assessed once. Second, given the observational design, causality could not be inferred. 
Relatedly, there may be unobserved confounders including parental mental health problems 
or disorders other than antenatal maternal depression. Third, internalising and externalising 
symptoms in children were reported by mothers, which may raise concerns about potential 
reporter bias. However, we controlled for maternal depression and thus likely reduced 





Our findings suggest that low-grade inflammation during childhood may increase risk of 
psychotic-like experiences in early adulthood via increased childhood internalising 
symptoms. Both internalising symptoms (van de Pavert et al., 2017) and inflammation are 
associated with a greater risk of developing chronic physical disorders, which are often 
comorbid with psychosis (Hert et al., 2011) and thought to represent a phenotypic 
manifestation of a shared pathophysiological background (Minichino et al., 2017). These 
findings, obtained from a large, general population sample, provide an additional step 
towards understanding the relationship between inflammation and symptoms of the psychosis 
continuum.  
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